Both in Pharmaceuticals
TG Therapeutics vs Spyre Therapeutics
Over the past year TGTX returned +82.3% and SYRE returned +331.0%; their daily moves had a correlation of 0.33.
TGTX +82.3% SYRE +331.0%Growth of $1, one year, split-adjusted
| Metric | TGTX | SYRE |
|---|---|---|
| Price | $61.63 | $99.04 |
| Market cap | $9.43B | $9.26B |
| Today | +1.45% | −0.23% |
| 1 month | +18.1% | +23.6% |
| 6 months | +46.8% | +35.7% |
| Year to date | +106.7% | +202.3% |
| 1 year | +82.9% | +316.5% |
| Revenue growth (YoY) | +70.3% | — |
| Gross margin | 82.9% | — |
| Net margin | 3.2% | — |
| P/E (TTM) | 21.4× | — |
| Price / sales | 11.8× | — |
| Net cash | -$193.1M | $1.07B |
| Dividend yield | — | — |
| Volatility (60d) | 36.8% | 59.0% |
| Short % of float | 20.1% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).